Fundz

Biosion, Inc. Appoints Furqan Ahmed, PharmD as Vice President and Head of Business Development

PRIVATEJul 05, 2023

Position

Head of Business Development

Company

Biosion

Furqan Ahmed
furqan.ahmed@biosion.com
NanjingBiotechnologyHealth CareTherapeutics

Description

Biosion, Inc. , a global, clinical-stage biotechnology company, today announced the appointment of Furqan Ahmed, PharmD., as the Vice President and Head of Business Development. In this position, Furqan will be responsible for all aspects of the company's global business development efforts to maximize the value of Biosion's platforms and innovative pipeline.

Quick answer

Biosion, Inc. Appoints Furqan Ahmed, PharmD as Vice President and Head of Business Development (July 5, 2023). Biosion is based in Nanjing, Jiangsu, China.

Who is the new Head of Business Development at Biosion?
Biosion named Furqan Ahmed Head of Business Development, announced July 5, 2023.
What did Biosion announce on July 5, 2023?
Biosion, Inc. , a global, clinical-stage biotechnology company, today announced the appointment of Furqan Ahmed, PharmD., as the Vice President and Head of Business Development. In this position, Furqan will be responsible for all aspects of the company's global business development efforts to maximize the value of Biosion's platforms and innovative pipeline.
What does Biosion do?
Biosion is a global, clinical-stage biotechnology company committed to developing breakthrough antibody-based therapies to improve patient outcomes for the treatment of immune and oncologic diseases.
Where is Biosion based?
Biosion is based in Nanjing, Jiangsu, China.
Which similar companies made leadership changes around the same time?
Akamis Bio (July 6, 2023), EyePoint, Inc. (July 10, 2023), MBX Biosciences, Inc. (July 10, 2023) and AbbVie Inc. (June 29, 2023) also announced leadership changes within 45 days of Biosion.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Biosion, and when

A new leader at Biosion brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Biosion raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Biosion, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Biosion. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Biosion

Location

Nanjing, Jiangsu, China

About

Biosion is a global, clinical-stage biotechnology company committed to developing breakthrough antibody-based therapies to improve patient outcomes for the treatment of immune and oncologic diseases. Established in 2017, Biosion has built a pipeline of innovative biologics through its internally derived proprietary technologies including the H3 antibody discovery platform, SynTracer HT® endocytosis platform, and Flexibody® bispecific platform. Biosion's lead asset, BSI-045B (anti-TSLP mAb), is currently in phase-II for severe asthma and atopic dermatitis, with another 4 partnered assets in phase-I/II. Biosion and partners have plans to progress the immune-oncology and antibody drug conjugate-based portfolio into clinical trials for oncology indications over the next year. Biosion has operations in the US, Australia, and China.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Biosion changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Furqan
Likely contact at this company
••••••••@••••••••

See Furqan's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Biosion's next move

Learn about Strategic plan

Biosion changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.